News & Analysis on Clinical Trial Services & Contract Research And Development
I-Mab and WuXi Biologics extend their strategic partnership for biologics process development as well as clinical and commercial manufacturing to accelerate drug development in China and abroad.
Circuit Clinical is providing digital and clinical services as part of its collaboration with a NY-based cancer center, patients at which will have expanded opportunities to participate in clinical trials.
Completion of early-stage development site expansion at the Illinois Science and Technology Park supplies Chicago-based drug companies with refrigeration services for complex APIs.
Acorn AI is designed to answer questions across all phases of drug development, making data “liquid” to help pharma make quick “go/no-go” decisions, accelerate clinical trials, and demonstrate value.
The $226m licensing agreement sees the development and commercialization of a targeted treatment for pancreatic and hard to treat cancers in China.
Industry welcomes the European Parliament’s decision to endorse the provisional funding agreement for Horizon Europe.